We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Viral infections caused by Flu A, Flu B, RSV and SARS-CoV-2 have similar clinical presentations, but the treatment options are different, the company noted. Read More
Clinical laboratory staff and healthcare providers should consider confirming results obtained using BD’s test with an alternate authorized test, the FDA said. Read More
Australia’s Therapeutic Goods Administration (TGA) said it is reviewing all approved serology-based COVID-19 point-of-care tests to verify their ability to detect SARS-COV-2 antibodies. Read More
After a lengthy review, the U.S. Pharmacopeia (USP) has decided to continue recommending the use of decades-old reagents derived from horseshoe crab blood for detecting endotoxins in drugs rather than press for the use of new synthetic substitutes. Read More
RSS
